• Home
  • Our Discovery
  • Market Opportunity
  • Management
  • Partnering
  • News
  • Legal Notices
  • Media
  • News Archive
  • More
    • Home
    • Our Discovery
    • Market Opportunity
    • Management
    • Partnering
    • News
    • Legal Notices
    • Media
    • News Archive
  • Home
  • Our Discovery
  • Market Opportunity
  • Management
  • Partnering
  • News
  • Legal Notices
  • Media
  • News Archive
Vivacelle Bio Inc.

Biotech Executive Conversations

Biotech Executive Conversation between Vivacelle Bio's CEO, Harven DeShield, Ph.D., JD and Mr. Berthran Ugeh, partner of a Hedge Fund and CEO of Tendy LLC.

Harven de shield talks startups

  

Harven de Shield, PhD, JD, General Counsel of Vivacelle talks startups

43 North Finals pitch - vivacelle bio

 Vivacelle Bio, Incorporated is thrilled to be a @forty3north semifinalist and to move on to the next round of the $5M startup competition!  This year, over 500 startups from across North America submitted applications to 43North to complete for $5 million in cash awards! Vivacelle Bio, Incorporated is proud to be among the 134 semifinalists chosen. 

VIVACELLE INTERVIEW CONDUCTED IN 09.2019

Copyright © 2023 Vivacelle Bio Inc. - All Rights Reserved.

Powered by GoDaddy Website Builder

  • Home
  • Market Opportunity
  • Management
  • News
  • Legal Notices

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept